Altre lingue Pharmagreen Biotech Inc.

Azioni

PHBI

US71716C1099

Tempo differito OTC Markets Altri mercati azionari 17:05:19 28/06/2024			Variaz. 5gg	Var. 1 gen.
0,0008 ^USD	0,00%		0,00%	+33,33%

20/05	Pharmagreen Biotech Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 marzo 2024	CI
21/02	Pharmagreen Biotech Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	20/05
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	21/02
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/01
Sub-Penny Momentum Watchlist (TMGI, BEGI, PHBI, ABQQ)	07/11
Pharmagreen Biotech Inc. cancelled the transaction announced on November 2, 2022	02/11
PHBI – Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation	05/09/23
Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.Com and Develops Its Next Pre-Workout Formulation	05/09/23
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14/08/23
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	19/05/23
PHARMAGREEN BIOTECH INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	18/05/23
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	14/02/23
PHARMAGREEN BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/02/23
Pharmagreen Biotech, Inc. Launches Online Sales for Its MaxGenomic(TM) Supplement Product	08/02/23
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product	08/02/23
PHARMAGREEN BIOTECH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	17/01/23
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	17/01/23
Pharmagreen Biotech Inc. Auditor Raises 'Going Concern' Doubt	17/01/23
PHARMAGREEN BIOTECH INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	02/12/22
Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador	29/11/22
Pharmagreen Biotech Inc. announced that it expects to receive $0.05 million in funding from JanBella Group, LLC	02/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pharmagreen Biotech Inc.

Azioni

PHBI

US71716C1099

Altre lingue

Filtri